Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/14/04 → 10/31/08 |
Funding
- Eli Lilly and Company: $24,295.00
A Randomized Phase 3 Trial of ALIMTA and Cisplatin versus GEMZAR and Cisplatin in Patients with Locally Advanced or Metastatic Non-Small Lung Cancer
- Arnold, Susanne (PI)